The Dependency Map (DepMap) is a genome-wide pooled CRISPR-Cas9 knockout proliferation screen conducted in more than 700 cancer cell lines spanning many different tumor lineages. Each cell line in the DepMap contains a unique barcode, and each gene knockout is assigned a “dependency score” on a per cell-line basis which quantifies the rate of CRISPR-Cas9 guide drop. It has been found that proteins with similar DepMap scores across cell lines, a phenomenon known as co-dependent genes, have closely related biological functions. This can include activity in the same or parallel pathways or membership in the same protein complex or the same pathway.
We identified the strongest seven co-dependent genes (“Symbol”) for DUBs and ran GO enrichment analysis. We used Biogrid, IntAct, and Pathway Commons PPIDs, and the NURSA protein-protein interaction databases (PPIDs) to determine whether co-dependent genes interact with one another. The “Evidence” column contains the PPIDs in which the interaction appears as well as whether there is support for the association by an INDRA statement. As another approach to identify potential interactors, we looked at proteomics data from the Broad Institute's Cancer Cell Line Encyclopedia (CCLE) for proteins whose expression across ~375 cell lines strongly correlated with the abundance of each DUB; it has previously been observed that proteins in the same complex are frequently significantly co-expressed. The correlations and associated p-values in the CCLE proteomics dataset are provided. And, we determined whether co-dependent genes yield similar transcriptomic signatures in the Broad Institute's Connectivity Map (CMap). A CMap score greater than 90 is considered significantly similar.
Symbol | Name | DepMap Correlation | Evidence | CCLE Correlation | CCLE Z-score | CCLE p-value (adj) | CCLE Significant | CMAP Score | CMAP Type |
---|
Gene set enrichment analysis was done on the genes correlated with YOD1using the terms from Gene Ontology and gene sets derived from the Gene Ontology Annotations database via MSigDB.
Using the biological processes and other Gene Ontology terms from well characterized DUBs as a positive control, several gene set enrichment analyses were considered. Threshold-less methods like GSEA had relatively poor results. Over-representation analysis with a threshold of of the top 7 highest absolute value Dependency Map correlations yielded the best results and is reported below.
GO Identifier | GO Name | GO Type | p-value | p-value (adj.) | q-value |
---|
The following table shows the significantly differentially expressed genes after knocking out YOD1 using CRISPR-Cas9.
The GSEA method was applied for all genes whose knockout resulted in at least 20 significantly differentially expressed genes.
ID | Name | p-value | p-value (adj.) | log2 Error | ES | NES |
---|---|---|---|---|---|---|
msig:M5893 | HALLMARK_MITOTIC_SPINDLE | 3.75e-10 | 9.09e-07 | 8.14e-01 | 6.49e-01 | 2.42e+00 |
go:0042393 | histone binding | 5.39e-08 | 5.32e-05 | 7.20e-01 | 6.50e-01 | 2.32e+00 |
go:0033044 | regulation of chromosome organization | 6.58e-08 | 5.32e-05 | 7.05e-01 | 5.43e-01 | 2.20e+00 |
go:0045787 | positive regulation of cell cycle | 2.26e-06 | 1.09e-03 | 6.27e-01 | 4.93e-01 | 2.02e+00 |
go:0051276 | chromosome organization | 2.86e-06 | 1.09e-03 | 6.27e-01 | 3.68e-01 | 1.73e+00 |
go:0045944 | positive regulation of transcription by RNA polymerase II | 3.15e-06 | 1.09e-03 | 6.27e-01 | 4.19e-01 | 1.86e+00 |
go:0033043 | regulation of organelle organization | 9.07e-06 | 2.75e-03 | 5.93e-01 | 3.47e-01 | 1.65e+00 |
go:2001251 | negative regulation of chromosome organization | 1.17e-05 | 3.16e-03 | 5.93e-01 | 6.13e-01 | 2.14e+00 |
go:0007010 | cytoskeleton organization | 1.94e-05 | 4.52e-03 | 5.76e-01 | 3.62e-01 | 1.69e+00 |
go:0050728 | negative regulation of inflammatory response | 2.05e-05 | 4.52e-03 | 5.76e-01 | -7.24e-01 | -2.18e+00 |
go:0006091 | generation of precursor metabolites and energy | 2.66e-05 | 4.97e-03 | 5.76e-01 | -3.55e-01 | -1.73e+00 |
go:0008144 | drug binding | 2.51e-05 | 4.97e-03 | 5.76e-01 | 3.49e-01 | 1.65e+00 |
go:0031252 | cell leading edge | 3.10e-05 | 5.01e-03 | 5.57e-01 | 5.07e-01 | 1.98e+00 |
go:0051726 | regulation of cell cycle | 2.97e-05 | 5.01e-03 | 5.76e-01 | 3.48e-01 | 1.64e+00 |
go:0045931 | positive regulation of mitotic cell cycle | 3.52e-05 | 5.18e-03 | 5.57e-01 | 5.61e-01 | 2.00e+00 |
go:0003700 | DNA-binding transcription factor activity | 3.63e-05 | 5.18e-03 | 5.57e-01 | 4.14e-01 | 1.79e+00 |
go:0030554 | adenyl nucleotide binding | 3.95e-05 | 5.32e-03 | 5.57e-01 | 3.48e-01 | 1.64e+00 |
go:0005819 | spindle | 4.57e-05 | 5.83e-03 | 5.57e-01 | 4.53e-01 | 1.88e+00 |
go:0007049 | cell cycle | 5.18e-05 | 6.29e-03 | 5.57e-01 | 3.06e-01 | 1.52e+00 |
go:0140053 | mitochondrial gene expression | 6.13e-05 | 6.76e-03 | 5.38e-01 | -4.58e-01 | -1.92e+00 |
go:0005694 | chromosome | 5.96e-05 | 6.76e-03 | 5.57e-01 | 3.45e-01 | 1.62e+00 |
go:0006325 | chromatin organization | 7.30e-05 | 7.69e-03 | 5.38e-01 | 3.92e-01 | 1.74e+00 |
go:0009891 | positive regulation of biosynthetic process | 7.92e-05 | 8.00e-03 | 5.38e-01 | 3.25e-01 | 1.57e+00 |
msig:M5935 | HALLMARK_FATTY_ACID_METABOLISM | 8.49e-05 | 8.24e-03 | 5.38e-01 | -4.98e-01 | -1.96e+00 |
go:0032553 | ribonucleotide binding | 1.03e-04 | 9.65e-03 | 5.38e-01 | 3.27e-01 | 1.58e+00 |
go:0051052 | regulation of DNA metabolic process | 1.26e-04 | 1.09e-02 | 5.19e-01 | 4.84e-01 | 1.88e+00 |
go:0090068 | positive regulation of cell cycle process | 1.26e-04 | 1.09e-02 | 5.19e-01 | 4.80e-01 | 1.88e+00 |
msig:M5942 | HALLMARK_UV_RESPONSE_DN | 1.31e-04 | 1.10e-02 | 5.19e-01 | 6.26e-01 | 2.00e+00 |
go:0044430 | 1.49e-04 | 1.16e-02 | 5.19e-01 | 3.22e-01 | 1.54e+00 | |
go:0000922 | spindle pole | 1.48e-04 | 1.16e-02 | 5.19e-01 | 5.29e-01 | 1.93e+00 |
go:0008092 | cytoskeletal protein binding | 1.77e-04 | 1.34e-02 | 5.19e-01 | 3.69e-01 | 1.68e+00 |
reactome:R-HSA-917729 | Endosomal Sorting Complex Required For Transport (ESCRT) | 2.22e-04 | 1.54e-02 | 5.19e-01 | -7.30e-01 | -2.08e+00 |
go:0003723 | RNA binding | 2.31e-04 | 1.55e-02 | 5.19e-01 | 2.74e-01 | 1.40e+00 |
go:0006302 | double-strand break repair | 2.56e-04 | 1.68e-02 | 4.98e-01 | 5.51e-01 | 1.95e+00 |
go:0000278 | mitotic cell cycle | 2.73e-04 | 1.70e-02 | 4.98e-01 | 3.20e-01 | 1.51e+00 |
go:0004386 | helicase activity | 2.68e-04 | 1.70e-02 | 4.98e-01 | 5.53e-01 | 1.93e+00 |
go:0007051 | spindle organization | 2.81e-04 | 1.70e-02 | 4.98e-01 | 5.03e-01 | 1.88e+00 |
go:0010639 | negative regulation of organelle organization | 3.54e-04 | 1.94e-02 | 4.98e-01 | 4.22e-01 | 1.74e+00 |
go:0098813 | nuclear chromosome segregation | 3.60e-04 | 1.94e-02 | 4.98e-01 | 4.70e-01 | 1.84e+00 |
go:0010628 | positive regulation of gene expression | 3.60e-04 | 1.94e-02 | 4.98e-01 | 3.12e-01 | 1.51e+00 |
msig:M5901 | HALLMARK_G2M_CHECKPOINT | 3.56e-04 | 1.94e-02 | 4.98e-01 | 4.27e-01 | 1.75e+00 |
go:0003779 | actin binding | 3.58e-04 | 1.94e-02 | 4.98e-01 | 4.24e-01 | 1.72e+00 |
go:0007163 | establishment or maintenance of cell polarity | 3.71e-04 | 1.96e-02 | 4.98e-01 | 5.43e-01 | 1.92e+00 |
msig:M14314 | KEGG_PURINE_METABOLISM | 3.84e-04 | 1.98e-02 | 4.98e-01 | -5.28e-01 | -1.98e+00 |
go:0044429 | 4.56e-04 | 2.30e-02 | 4.98e-01 | -2.81e-01 | -1.46e+00 | |
go:2001252 | positive regulation of chromosome organization | 4.76e-04 | 2.36e-02 | 4.98e-01 | 5.10e-01 | 1.86e+00 |
go:0000226 | microtubule cytoskeleton organization | 5.21e-04 | 2.53e-02 | 4.77e-01 | 3.98e-01 | 1.71e+00 |
go:0007017 | microtubule-based process | 5.70e-04 | 2.66e-02 | 4.77e-01 | 3.69e-01 | 1.64e+00 |
reactome:R-HSA-977225 | Amyloid fiber formation | 5.69e-04 | 2.66e-02 | 4.77e-01 | -6.51e-01 | -1.96e+00 |
go:0005874 | microtubule | 6.01e-04 | 2.75e-02 | 4.77e-01 | 4.17e-01 | 1.70e+00 |
go:0010564 | regulation of cell cycle process | 6.20e-04 | 2.78e-02 | 4.77e-01 | 3.38e-01 | 1.57e+00 |
go:0005770 | late endosome | 6.73e-04 | 2.97e-02 | 4.77e-01 | -4.78e-01 | -1.86e+00 |
go:0000819 | sister chromatid segregation | 7.12e-04 | 3.08e-02 | 4.77e-01 | 4.81e-01 | 1.82e+00 |
msig:M5936 | HALLMARK_OXIDATIVE_PHOSPHORYLATION | 7.49e-04 | 3.16e-02 | 4.77e-01 | -3.55e-01 | -1.63e+00 |
go:0050839 | cell adhesion molecule binding | 7.58e-04 | 3.16e-02 | 4.77e-01 | 3.60e-01 | 1.60e+00 |
go:0051983 | regulation of chromosome segregation | 7.69e-04 | 3.16e-02 | 4.77e-01 | 5.54e-01 | 1.87e+00 |
go:0099080 | supramolecular complex | 8.18e-04 | 3.31e-02 | 4.77e-01 | 3.60e-01 | 1.60e+00 |
go:0006310 | DNA recombination | 9.04e-04 | 3.59e-02 | 4.77e-01 | 4.68e-01 | 1.75e+00 |
go:0000726 | non-recombinational repair | 9.33e-04 | 3.64e-02 | 4.77e-01 | 6.41e-01 | 1.86e+00 |
go:0000018 | regulation of DNA recombination | 9.46e-04 | 3.64e-02 | 4.77e-01 | 6.84e-01 | 1.92e+00 |
go:0051783 | regulation of nuclear division | 9.84e-04 | 3.73e-02 | 4.55e-01 | 4.74e-01 | 1.80e+00 |
go:0043565 | sequence-specific DNA binding | 1.03e-03 | 3.85e-02 | 4.55e-01 | 3.87e-01 | 1.67e+00 |
go:0003682 | chromatin binding | 1.07e-03 | 3.93e-02 | 4.55e-01 | 3.99e-01 | 1.68e+00 |
go:0044463 | 1.09e-03 | 3.93e-02 | 4.55e-01 | 3.48e-01 | 1.58e+00 | |
go:0016071 | mRNA metabolic process | 1.11e-03 | 3.94e-02 | 4.55e-01 | 3.27e-01 | 1.52e+00 |
go:0000228 | nuclear chromosome | 1.19e-03 | 4.19e-02 | 4.55e-01 | 3.65e-01 | 1.58e+00 |
go:0032838 | plasma membrane bounded cell projection cytoplasm | 1.22e-03 | 4.22e-02 | 4.55e-01 | 5.68e-01 | 1.84e+00 |
go:0014070 | response to organic cyclic compound | 1.27e-03 | 4.26e-02 | 4.55e-01 | 3.58e-01 | 1.57e+00 |
go:0051129 | negative regulation of cellular component organization | 1.28e-03 | 4.26e-02 | 4.55e-01 | 3.54e-01 | 1.55e+00 |
go:0015630 | microtubule cytoskeleton | 1.32e-03 | 4.29e-02 | 4.55e-01 | 3.22e-01 | 1.51e+00 |
reactome:R-HSA-71387 | Metabolism of carbohydrates | 1.33e-03 | 4.29e-02 | 4.55e-01 | -4.32e-01 | -1.75e+00 |
reactome:R-HSA-72306 | tRNA processing | 1.35e-03 | 4.31e-02 | 4.55e-01 | -5.44e-01 | -1.91e+00 |
go:0032543 | mitochondrial translation | 1.38e-03 | 4.32e-02 | 4.55e-01 | -4.16e-01 | -1.72e+00 |
reactome:R-HSA-397014 | Muscle contraction | 1.40e-03 | 4.32e-02 | 4.55e-01 | 5.76e-01 | 1.84e+00 |
go:0005740 | mitochondrial envelope | 1.47e-03 | 4.46e-02 | 4.55e-01 | -2.69e-01 | -1.38e+00 |
go:0016887 | ATPase activity | 1.66e-03 | 4.62e-02 | 4.55e-01 | 3.88e-01 | 1.64e+00 |
go:0140014 | mitotic nuclear division | 1.62e-03 | 4.62e-02 | 4.55e-01 | 3.98e-01 | 1.61e+00 |
go:0030424 | axon | 1.60e-03 | 4.62e-02 | 4.55e-01 | 4.11e-01 | 1.65e+00 |
go:0071407 | cellular response to organic cyclic compound | 1.65e-03 | 4.62e-02 | 4.55e-01 | 3.92e-01 | 1.61e+00 |
go:0030175 | filopodium | 1.66e-03 | 4.62e-02 | 4.55e-01 | 6.65e-01 | 1.87e+00 |
go:0019068 | virion assembly | 1.62e-03 | 4.62e-02 | 4.55e-01 | -6.37e-01 | -1.88e+00 |
msig:M5898 | HALLMARK_DNA_REPAIR | 1.77e-03 | 4.88e-02 | 4.55e-01 | -4.29e-01 | -1.75e+00 |
go:0071887 | leukocyte apoptotic process | 1.86e-03 | 5.01e-02 | 4.55e-01 | -6.15e-01 | -1.93e+00 |
go:0007346 | regulation of mitotic cell cycle | 1.88e-03 | 5.01e-02 | 4.55e-01 | 3.34e-01 | 1.53e+00 |
go:0072686 | mitotic spindle | 1.93e-03 | 5.10e-02 | 4.55e-01 | 5.16e-01 | 1.78e+00 |
go:0007059 | chromosome segregation | 2.15e-03 | 5.61e-02 | 4.32e-01 | 3.94e-01 | 1.60e+00 |
reactome:R-HSA-5368287 | Mitochondrial translation | 2.26e-03 | 5.80e-02 | 4.32e-01 | -4.23e-01 | -1.71e+00 |
go:0008017 | microtubule binding | 2.27e-03 | 5.80e-02 | 4.32e-01 | 4.88e-01 | 1.76e+00 |
go:0000785 | chromatin | 2.37e-03 | 5.87e-02 | 4.32e-01 | 3.75e-01 | 1.59e+00 |
go:0140030 | modification-dependent protein binding | 2.34e-03 | 5.87e-02 | 4.32e-01 | 5.88e-01 | 1.83e+00 |
go:0045296 | cadherin binding | 2.45e-03 | 5.87e-02 | 4.32e-01 | 3.60e-01 | 1.57e+00 |
go:0000070 | mitotic sister chromatid segregation | 2.50e-03 | 5.87e-02 | 4.32e-01 | 4.67e-01 | 1.73e+00 |
go:0002285 | lymphocyte activation involved in immune response | 2.51e-03 | 5.87e-02 | 4.32e-01 | 5.99e-01 | 1.76e+00 |
go:0003690 | double-stranded DNA binding | 2.52e-03 | 5.87e-02 | 4.32e-01 | 3.79e-01 | 1.61e+00 |
go:0050000 | chromosome localization | 2.54e-03 | 5.87e-02 | 4.32e-01 | 5.95e-01 | 1.83e+00 |
go:0022402 | cell cycle process | 2.44e-03 | 5.87e-02 | 4.32e-01 | 2.91e-01 | 1.41e+00 |
go:0005126 | cytokine receptor binding | 2.39e-03 | 5.87e-02 | 4.32e-01 | -5.40e-01 | -1.85e+00 |
go:0051301 | cell division | 2.59e-03 | 5.93e-02 | 4.32e-01 | 3.38e-01 | 1.51e+00 |
go:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 2.78e-03 | 6.31e-02 | 4.32e-01 | -5.53e-01 | -1.87e+00 |
go:0045935 | positive regulation of nucleobase-containing compound metabolic process | 2.84e-03 | 6.39e-02 | 4.32e-01 | 4.33e-01 | 1.66e+00 |
go:0016817 | hydrolase activity, acting on acid anhydrides | 2.91e-03 | 6.47e-02 | 4.32e-01 | 3.11e-01 | 1.44e+00 |
go:0032204 | regulation of telomere maintenance | 3.14e-03 | 6.57e-02 | 4.32e-01 | 5.74e-01 | 1.78e+00 |
go:0070126 | mitochondrial translational termination | 3.10e-03 | 6.57e-02 | 4.32e-01 | -4.21e-01 | -1.69e+00 |
go:0030010 | establishment of cell polarity | 3.14e-03 | 6.57e-02 | 4.32e-01 | 5.94e-01 | 1.78e+00 |
go:0042641 | actomyosin | 3.08e-03 | 6.57e-02 | 4.32e-01 | 6.56e-01 | 1.84e+00 |
go:0048285 | organelle fission | 3.13e-03 | 6.57e-02 | 4.32e-01 | 3.73e-01 | 1.58e+00 |
go:2000106 | regulation of leukocyte apoptotic process | 3.02e-03 | 6.57e-02 | 4.32e-01 | -6.21e-01 | -1.84e+00 |
go:0008380 | RNA splicing | 3.01e-03 | 6.57e-02 | 4.32e-01 | 3.27e-01 | 1.50e+00 |
go:0010638 | positive regulation of organelle organization | 3.18e-03 | 6.59e-02 | 4.32e-01 | 3.36e-01 | 1.49e+00 |
reactome:R-HSA-5578749 | Transcriptional regulation by small RNAs | 3.38e-03 | 6.85e-02 | 4.32e-01 | -5.29e-01 | -1.81e+00 |
go:1902275 | regulation of chromatin organization | 3.38e-03 | 6.85e-02 | 4.32e-01 | 4.94e-01 | 1.72e+00 |
reactome:R-HSA-211000 | Gene Silencing by RNA | 3.39e-03 | 6.85e-02 | 4.32e-01 | -5.20e-01 | -1.83e+00 |
go:0000910 | cytokinesis | 3.44e-03 | 6.89e-02 | 4.32e-01 | 4.95e-01 | 1.77e+00 |
go:0015631 | tubulin binding | 3.50e-03 | 6.91e-02 | 4.32e-01 | 4.22e-01 | 1.64e+00 |
go:0032432 | actin filament bundle | 3.59e-03 | 7.01e-02 | 4.32e-01 | 6.65e-01 | 1.83e+00 |
go:0120111 | neuron projection cytoplasm | 3.72e-03 | 7.11e-02 | 4.32e-01 | 5.87e-01 | 1.72e+00 |
go:0070849 | response to epidermal growth factor | 3.72e-03 | 7.11e-02 | 4.32e-01 | 6.63e-01 | 1.83e+00 |
go:0006415 | translational termination | 3.69e-03 | 7.11e-02 | 4.32e-01 | -3.93e-01 | -1.61e+00 |
go:0042326 | negative regulation of phosphorylation | 3.79e-03 | 7.12e-02 | 4.32e-01 | 3.82e-01 | 1.55e+00 |
go:0034728 | nucleosome organization | 3.81e-03 | 7.12e-02 | 4.32e-01 | 4.90e-01 | 1.71e+00 |
reactome:R-HSA-5689880 | Ub-specific processing proteases | 3.80e-03 | 7.12e-02 | 4.32e-01 | -3.95e-01 | -1.61e+00 |
go:0015980 | energy derivation by oxidation of organic compounds | 3.87e-03 | 7.16e-02 | 4.32e-01 | -3.47e-01 | -1.56e+00 |
go:0002703 | regulation of leukocyte mediated immunity | 4.10e-03 | 7.47e-02 | 4.07e-01 | 6.27e-01 | 1.80e+00 |
go:0032206 | positive regulation of telomere maintenance | 4.22e-03 | 7.60e-02 | 4.07e-01 | 5.81e-01 | 1.71e+00 |
go:0051054 | positive regulation of DNA metabolic process | 4.36e-03 | 7.60e-02 | 4.07e-01 | 4.89e-01 | 1.73e+00 |
go:0042026 | protein refolding | 4.31e-03 | 7.60e-02 | 4.07e-01 | 6.34e-01 | 1.78e+00 |
go:0005759 | mitochondrial matrix | 4.35e-03 | 7.60e-02 | 4.07e-01 | -3.21e-01 | -1.50e+00 |
go:0003724 | RNA helicase activity | 4.31e-03 | 7.60e-02 | 4.07e-01 | 6.26e-01 | 1.79e+00 |
go:0008094 | DNA-dependent ATPase activity | 4.54e-03 | 7.85e-02 | 4.07e-01 | 5.80e-01 | 1.78e+00 |
go:1902850 | microtubule cytoskeleton organization involved in mitosis | 4.57e-03 | 7.85e-02 | 4.07e-01 | 4.73e-01 | 1.71e+00 |
reactome:R-HSA-1226099 | Signaling by FGFR in disease | 4.64e-03 | 7.93e-02 | 4.07e-01 | -5.83e-01 | -1.83e+00 |
msig:M4013 | KEGG_GAP_JUNCTION | 4.73e-03 | 7.97e-02 | 4.07e-01 | -6.53e-01 | -1.86e+00 |
go:0099513 | polymeric cytoskeletal fiber | 4.72e-03 | 7.97e-02 | 4.07e-01 | 3.53e-01 | 1.51e+00 |
go:0016569 | covalent chromatin modification | 4.87e-03 | 8.14e-02 | 4.07e-01 | 3.74e-01 | 1.52e+00 |
go:0006974 | cellular response to DNA damage stimulus | 4.91e-03 | 8.16e-02 | 4.07e-01 | 3.14e-01 | 1.44e+00 |
go:0006954 | inflammatory response | 5.11e-03 | 8.26e-02 | 4.07e-01 | -3.57e-01 | -1.54e+00 |
reactome:R-HSA-445355 | Smooth Muscle Contraction | 5.09e-03 | 8.26e-02 | 4.07e-01 | 6.53e-01 | 1.80e+00 |
go:0009890 | negative regulation of biosynthetic process | 5.06e-03 | 8.26e-02 | 4.07e-01 | 2.96e-01 | 1.39e+00 |
reactome:R-HSA-6781823 | Formation of TC-NER Pre-Incision Complex | 5.07e-03 | 8.26e-02 | 4.07e-01 | -5.49e-01 | -1.84e+00 |
go:0005681 | spliceosomal complex | 5.15e-03 | 8.26e-02 | 4.07e-01 | 3.71e-01 | 1.52e+00 |
go:0044087 | regulation of cellular component biogenesis | 5.29e-03 | 8.45e-02 | 4.07e-01 | 3.20e-01 | 1.45e+00 |
go:0051240 | positive regulation of multicellular organismal process | 5.54e-03 | 8.71e-02 | 4.07e-01 | 2.97e-01 | 1.38e+00 |
go:0034399 | nuclear periphery | 5.57e-03 | 8.71e-02 | 4.07e-01 | 4.80e-01 | 1.68e+00 |
go:0005876 | spindle microtubule | 5.54e-03 | 8.71e-02 | 4.07e-01 | 5.87e-01 | 1.70e+00 |
go:0051130 | positive regulation of cellular component organization | 5.85e-03 | 9.08e-02 | 4.07e-01 | 2.97e-01 | 1.39e+00 |
go:1902115 | regulation of organelle assembly | 5.88e-03 | 9.08e-02 | 4.07e-01 | 4.60e-01 | 1.64e+00 |
reactome:R-HSA-8951664 | Neddylation | 6.08e-03 | 9.31e-02 | 4.07e-01 | -3.76e-01 | -1.57e+00 |
go:0005739 | mitochondrion | 6.11e-03 | 9.31e-02 | 4.07e-01 | -2.40e-01 | -1.29e+00 |
go:0071824 | protein-DNA complex subunit organization | 6.15e-03 | 9.32e-02 | 4.07e-01 | 3.98e-01 | 1.56e+00 |
go:0061061 | muscle structure development | 6.38e-03 | 9.61e-02 | 4.07e-01 | 3.83e-01 | 1.55e+00 |
reactome:R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | 6.50e-03 | 9.63e-02 | 4.07e-01 | -5.24e-01 | -1.78e+00 |
go:0006338 | chromatin remodeling | 6.48e-03 | 9.63e-02 | 4.07e-01 | 4.44e-01 | 1.62e+00 |
go:0016491 | oxidoreductase activity | 6.79e-03 | 9.91e-02 | 4.07e-01 | -2.89e-01 | -1.41e+00 |
go:0030030 | cell projection organization | 6.83e-03 | 9.91e-02 | 4.07e-01 | 3.02e-01 | 1.40e+00 |
msig:M5945 | HALLMARK_HEME_METABOLISM | 6.92e-03 | 9.99e-02 | 4.07e-01 | 4.72e-01 | 1.65e+00 |
INDRA was used to automatically assemble known mechanisms related to YOD1 from literature and knowledge bases. The first section shows only DUB activity and the second shows all other results.